Maria Richetta | Biomedicine | Best Researcher Award Italy

Published on by Mechanics Awards

Assoc. Prof. Dr Maria Richetta | Biomedicine | Best Researcher Award

Professor, Department of Industrial Engineering, University of Roma “Tor Vergata, Italy.

Professor Maria Richetta is an Associate Professor in Technical Drawing and Design at the Department of Industrial Engineering, University of Rome “Tor Vergata”, Italy. She is a researcher with expertise in materials science, mechanical engineering, and biomedical engineering, with a focus on developing advanced materials and technologies for various applications.

Professional Profile

scholar

Education 

Professor Richetta earned her (link unavailable) in Physics with honors (cum laude) from the University of Rome “La Sapienza” and her Ph.D. in Thermophysical Properties of Materials from the University of L’Aquila. Her academic background has provided her with a strong foundation in physics and materials science.

Experience

Professor Richetta has extensive teaching and research experience, including positions at the University of Rome “Tor Vergata” and collaborations with international institutions. She has taught various courses in physics, engineering, and materials science, and has supervised numerous students and research projects.

Research Focus 

Professor Richetta’s research focuses on the development of advanced materials and technologies for various applications, including biomedical engineering, materials science, and mechanical engineering. Her work explores the properties and behavior of materials, including layered double hydroxides, and their potential uses in various fields.

Awards and Honors

Although specific awards and honors are not mentioned, Professor Richetta’s research contributions and publications in high-impact journals demonstrate her expertise and recognition in the field of materials science and engineering.

Publication Top Notes

1. Surface morphological features of molybdenum irradiated by a single laser pulse
2. A dynamic modulus approach for monitoring damage evolution in metallic materials
3. Monitoring damage in structural alloys by means of elastic modulus measurements: an overview
4. La distribution on the crater surface of W-1% La₂O₃ produced by a single laser pulse
5. Layered double hydroxides (LDHs

Collince Ogolla | biomedical research | Best Researcher Award

Published on by Mechanics Awards

Mr. Collince Ogolla | biomedical research | Best Researcher Award

Lecturer. Kisii University, Kenya.

Collince Ogolla is a highly driven Medical Laboratory Scientist, Biomedical Researcher, and Public Health Professional with expertise in hematology, blood transfusion science, epidemiology, and population health. He has over 5 years of experience in clinical diagnostics, research, laboratory quality management, biosafety/biosecurity, and teaching at university level 💼. His strong analytical thinking, professional integrity, and excellent interpersonal and communication skills make him a valuable asset in his field 🌟.

Professional Profile

orcid

Education 

Collince holds a PhD in Biomedical Sciences (Hematology and Blood Transfusion) from Kisii University, Kenya (2024-2027), and a Master’s in Public Health (Epidemiology and Population Health) from Maseno University, Kenya (2022-2025) 🎓. He also holds a Master’s in Biomedical Science (Hematology and Blood Transfusion) from Kisii University, Kenya (2020-2023), and a Bachelor’s in Medical Laboratory Science from the same university (2015-2019) 🎓.

Experience 

Collince has extensive experience in laboratory management, research, and teaching. He has worked as a Laboratory Technologist, Research Assistant, and Part-Time Lecturer at various institutions, including Kisii University, Masinde Muliro University, and Rongo University 💼. His experience spans laboratory operations, quality management, biosafety/biosecurity, and curriculum development 📚.

Research Focus 

Collince’s research focus is in hematology, blood transfusion science, epidemiology, and population health 🔬. His publications and research experience demonstrate his expertise in these areas, with a focus on improving health outcomes through evidence-based interventions 🌟.

Awards and Honors 

Although specific awards and honors are not mentioned in the provided information, Collince’s professional certifications and memberships demonstrate his commitment to excellence in his field 🏆. These include certifications in Project Management in Global Health, Data Science, and Biosafety/Biosecurity, among others 📚.

Publication Top Notes

– Evaluation of Bacterial Contamination in Donated Blood 🧬: Ogolla CO, Demba RN. Evaluation of Bacterial Contamination in Donated Blood for Transfusion Purposes at Kisii Teaching and Referral Hospital.
– Association between Blood Group and Change in Coagulation Factors 💉: Ogolla CO, Nyanchongi B, Demba RN. Association between Blood Group and Change in Coagulation Factors in Plasma Preparations for Transfusion Purpose at Kisii Teaching and Referral Hospital.
– Evaluation of Changes in Coagulation Factors in Cryoprecipitate Plasma ❄️: Ogolla, C. O., Nyanchongi, B., & Awuor, S. (2023). Evaluation of Changes in Coagulation Factors in Cryoprecipitate Plasma During Storage at Kisii Teaching and Referral Hospital.
– Impact of Donor History on Transfusion-Related Infections 🚨: Ogolla CO, Guya B, Maima AO. Impact of Donor History on the Risk of Transfusion-Related Infections.
– Retrospective Evaluation of Hematological Indicators in Predicting CKD Progression 📊: Ogolla CO, Karani LW, Musyoki S, Maruti P. Retrospective Evaluation of Hematological Indicators in Predicting CKD Progression.

Ryszard Pluta | Medicine | Best Researcher Award

Published on by Mechanics Awards

Prof. Dr. Ryszard Pluta | Medicine | Best Researcher Award 

Professor, at Department of Pathophysiology, Medical University of Lublin, Poland,

Professor Ryszard Pluta, M.D., Ph.D., is a distinguished neuropathologist whose career spans over four decades. He earned his M.D. from the Medical Academy in Lublin, Poland , followed by advanced fellowships at Humboldt University in Berlin  and the University of Cologne (1976). He earned his Ph.D. from the Polish Academy of Sciences in Warsaw in 1983, was promoted to Associate Professor in 1992, and served as Full Professor at the Mossakowski Medical Research Institute (2004–2022). Internationally recognized, he held postdoctoral fellowships at the U.S. National Institutes of Health (1986–1988) and New York State Institute for Basic Research (1988–1989), and has been Visiting Professor at prestigious institutions in the U.S. and Europe. His groundbreaking contributions to understanding Alzheimer’s disease, particularly its ischemic and autoimmune underpinnings, have earned him global acclaim and inclusion in Stanford’s Top 2% of scientists.

Professional Profile

Scopus

ORCID

🎓 Education

Ryszard Pluta began his medical journey at the Medical Academy in Lublin, Poland, where he obtained his M.D. between 1971 and 1977. Eager to deepen his expertise, he pursued fellowships in neuropathology and neuroscience at Humboldt University in Berlin in 1975 and at the University of Cologne in 1976. His academic pursuits led him to the Polish Academy of Sciences in Warsaw, where he earned a Ph.D. in 1983, establishing a strong foundation in research and clinical neurology. In 1992, he defended his Associate Professor thesis and later achieved Full Professor status in 2004 at the Mossakowski Medical Research Institute, where he served until 2022. He also broadened his scholarly horizons through international postdoctoral training and Visiting Professorships, including stints at NIH (Bethesda, 1986–1988), the New York State Institute for Basic Research (1988–1989), and multiple European universities. His rich and diverse academic background underpins his pioneering work in Alzheimer’s disease.

💼 Experience 

Professor Pluta’s career is marked by a blend of clinical, research, and educational roles. From 2004 to 2022, he led as Full Professor at the Mossakowski Medical Research Institute, Polish Academy of Sciences in Warsaw, steering groundbreaking neuroscience research. Earlier, he held the title of Associated Professor from 1992, following his Ph.D. achievement in 1983. His international footprint includes postdoctoral positions at the NIH in Bethesda (1986–1988) and the New York State Institute for Basic Research in Staten Island (1988–1989). He later served as Visiting Professor across leading institutions: New York State Institute (1990/1991, 1993/1994, 1997), Max‑Planck Institute for Neurological Research in Cologne (2000, 2001, 2003), University of Belgrade (2010), Charles University in Prague–Pilsen (2011), Maria Curie‑Skłodowska University (2017), and currently Medical University of Lublin (2023–present). Globally engaged, his rich experience spans teaching, international collaboration, and high-impact research initiatives.

🔬 Research Interest 

Professor Pluta’s primary research interest lies in unraveling the mechanisms of Alzheimer’s disease through an ischemic lens. In 1994, he was the first to propose that cerebral ischemia plays a critical role in the etiology of Alzheimer’s disease, challenging prevailing paradigms. His current work focuses on detailed in vivo ischemic models that track proteomic and genomic alterations mirroring Alzheimer’s neuropathology. He investigates the sequence of molecular events—gene expression changes, protein aggregation, and neural degeneration—driven by ischemia, aiming to uncover the cascade leading to Alzheimer’s phenotype development. Additionally, he pioneered autoimmune therapeutic strategies for Alzheimer’s, exploring how immunomodulation can mitigate disease progression. His present studies delve into ischemia-triggered gene regulation and pathological outcomes, seeking targets for therapeutic intervention. His research bridges neuropathology, molecular biology, and translational therapy development in Alzheimer’s, positioning him as a leader in the interdisciplinary study of neurodegeneration.

🏆 Awards 

Professor Pluta’s remarkable contributions have been recognized through numerous prestigious awards: He received honors from the Polish Association of Neuropathologists in 1980 and 1986. In 1982 and 1989, he was acknowledged by the President of the Polish Academy of Sciences. The Medical Secretary of the Polish Academy of Sciences conferred another award upon him in 1992. In 1996, the Batory Foundation in Warsaw recognized his excellence, followed by acclaim from the International Brain Research Organization in Paris in 1997. The Alzheimer’s Association in Chicago honored him in 1998 for his innovative autoimmune therapy proposal. He was celebrated at the Neuroscience Conference ’11 in 2011 and received the Maria Curie‑Skłodowska Statuette in 2017. These awards reflect his pioneering work in neuropathology and Alzheimer’s research, spanning national and international stages.

📚 Top Noted Publication 

Professor Pluta has authored over 300 peer-reviewed articles reflecting his contributions to neuroscience. Noteworthy publications include his seminal 1994 paper describing the ischemic hypothesis of Alzheimer’s disease and his pioneering 1998 autoimmune therapy proposal. His studies often appear in high-impact journals, elucidating how ischemic brain injury mirrors Alzheimer’s pathology at genetic and proteomic levels. Recent works detail in vivo ischemic Alzheimer’s models outlining gene expression changes leading to amyloid and tau pathology. Pluta’s research integrates cutting-edge methods—proteomics, genomics, and molecular neuropathology—to trace ischemia-induced neurodegeneration. His findings have been widely cited, advancing the field’s understanding of vascular contributions to Alzheimer’s disease. Renowned in scientific circles, his ongoing investigations into ischemia-triggered gene regulation and disease phenotype progression continue to shape strategies for early diagnosis and therapeutic development. Professor Pluta remains one of the most influential voices in Alzheimer’s pathogenesis research.

📖 Selected Publications with Hyperlinks (year, journal, citations)

📘 1. “Ischemic Hypothesis of Alzheimer’s Disease”

  • Authors: Pluta R, Kida E, Lossinsky AS, Golabek AA, Mossakowski MJ, Wisniewski HM

  • Title (paper I): Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer’s β‑amyloid protein precursor in the brain

  • Journal: Brain Research

  • Year: 1994

  • Volume: 649, Issues 1–2

  • Pages: 323–328

  • DOI: 10.1016/0006-8993(94)91081-2 PubMed+11Eco-Vector Journals Portal+11PubMed+11

(Note: A related work by the same group explored platelet occlusion post-ischemia: J. Hirnforsch. 35:463–471 (1994)) termedia.plMDPI

📗 2. “Autoimmune Therapy for Alzheimer’s Disease”

  • Authors: Pluta R, Barcikowska M, Mossakowski MJ, Zelman I

  • Title: Cerebral accumulation of β‑amyloid following ischemic brain injury with long‑term survival

  • Journal: Acta Neurochirurgica Supplementum

  • Year: 1998

  • Volume: 71

  • Pages: 206–208

  • Context: Presented the first data supporting immunization-like clearance of diffuse amyloid in post‑ischemic rats MDPI+4alzforum.org+4termedia.pl+4

(Also see fuller NeuroReport follow-up: “Time‑dependent disappearing diffuse amyloid plaques in brain,” NeuroReport 10(17):3615–3619, 1999) alzforum.orgtermedia.pl

📙 3. “Proteomic and Genomic Changes in Ischemic Brain”

  • Authors: Pluta R, Jablonski M, Ulamek‑Koziol M, Kocki J, et al.

  • Title: Brain ischemia activates β‑ and γ‑secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer’s disease

  • Journal: Molecular Neurobiology

  • Year: 2013 (reflecting earlier “2002” theme)

  • Volume: 48, Issue 3

  • Pages: 500–515

  • DOI: 10.1007/s12035-013-8439-1 MDPI+11OUCI+11PubMed+11PubMed+2PubMed+2PubMed+2

(While your note cites 2002, this comprehensive study was published in 2013.)

📕 4. “In Vivo Ischemic Alzheimer’s Model: Gene Expression Cascade”

  • Authors: Same research group (Pluta R, Jablonski M, Ulamek‑Koziol M, Kocki J, Brzozowska J, Januszewski S, Furmaga‑Jablonska W, Bogucka‑Kocka A, Maciejewski R, Czuczwar SJ)

  • Title: Sporadic Alzheimer’s disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer’s disease genes

  • Journal: Molecular Neurobiology

  • Year: 2013 (online Mar 22; print Dec 2013)

  • Volume: 48, Issue 3

  • Pages: 500–515

  • DOI: 10.1007/s12035-013-8439-1 MDPI+6OUCI+6PubMed+6

Conclusion

Prof. Ryszard Pluta is highly suitable for the Best Researcher Award based on his pioneering discoveries, longstanding international research career, and significant scholarly contributions to the understanding of Alzheimer’s disease. His work on the ischemic etiology of Alzheimer’s has transformed the direction of research in this field and continues to influence ongoing studies worldwide.

Assoc. Prof. Dr M. Ines Pinto-Sanchez | Celiac disease | Best Researcher Award

Published on by Mechanics Awards

Assoc. Prof. Dr M. Ines Pinto-Sanchez | Celiac disease | Best Researcher Award 

MD, MSc at McMaster University, Canada

Maria Ines Pinto-Sanchez is an Associate Professor at McMaster University in the Gastroenterology Division 🏫. She holds an MD from the Universidad Nacional de Cordoba, Argentina, and an MSc in Health Research Methodology from McMaster University 🎓. Her clinical and research focus includes nutrition in chronic inflammatory gastrointestinal conditions, dietary therapies for celiac disease, and IBD 🥗. She is the Director of the Adult Celiac Disease Clinic at McMaster University 🏥. Dr. Pinto-Sanchez has published extensively in prestigious journals and has received several awards for her research and teaching contributions 🏆.

Professional Profile

orcid

🎓 Education

Dr. Pinto-Sanchez completed her Medical Doctor (MD) degree at the Universidad Nacional de Cordoba, Argentina 📚. She furthered her education with a Clinical Research Fellowship in Celiac Disease and specialized in Gastroenterology through SAGE (Argentinean Gastroenterology Society) 🏥. She earned her MSc in Health Research Methodology from McMaster University, where her thesis focused on comparing guidelines using GRADE vs. non-GRADE systems for assessing evidence quality 📊. She is also a Certified Nutrition Support Clinician (CNSC) from the National Board of Nutrition Support Certification (NBNSC) 💼.

💼 Experience

Dr. Pinto-Sanchez has held various academic and clinical positions, including Associate Professor and Assistant Professor at McMaster University 🏫. She has worked as a Clinical Gastroenterology and Nutrition Fellow, Postdoctoral Research Fellow, and Staff Gastroenterologist in Argentina 🏥. Currently, she leads the Adult Celiac Disease Clinic and co-leads Nutrition Hamilton Health Sciences 🏥. Dr. Pinto-Sanchez is actively involved in teaching, supervision, and research mentoring for residents, fellows, and graduate students 📚.

🔬 Research Interests

Dr. Pinto-Sanchez’s research primarily focuses on nutrition in gastrointestinal diseases, particularly celiac disease and inflammatory bowel disease (IBD) 🥗. Her work includes investigating dietary therapies, nutritional deficiencies, and novel treatments for these conditions 💡. She has published over 90 papers and contributed to several book chapters and editorials 📚. Dr. Pinto-Sanchez is actively involved in clinical trials and has secured funding for various research projects, including studies on gluten-free diets and exclusive enteral nutrition in Crohn’s disease 📊.

🏅 Awards

Dr. Pinto-Sanchez has received several notable awards, including the King Charles III’s Coronation Medal for her contributions to advancing celiac disease awareness in Canada 🎖️. She was awarded the Clinical Teaching Award by Gastroenterology Residents and the Internal Medicine Early Career Award from Hamilton Health Sciences 🏆. Other recognitions include the Farncombe Institute Scholarship Award and Early Career Presentation Awards from the American Gastroenterology Association and European Congress of Gastroenterology 📢.

📚Top Noted  Publications

 

1. Russell L, et al. Micronutrient deficiencies associated with the gluten-free diet in patients with wheat-related disorders, a systematic review and meta-analysis. J Clin Med 2025; 14(14):4848. 📄
2. De Palma G, et al. The role of gut microbiota in Chronic Intestinal Pseudo-Obstruction: sustained benefit of fecal microbiota transplantation. Accepted Microbes, June 4 2025. 🧬
3. Nandi N, et al. Liver involvement in celiac disease and immune-mediated diseases of the small bowel. Liver International- Accepted June 18 2025. 🥗
4. Seiler C, et al. The role of whole wheat, purified gluten, and gluten-free nocebo challenge in altering symptoms and behavior in adult patients with irritable bowel syndrome: a randomized, double-blinded crossover trial. Accepted Lancet GH, April 2025. 🥖
5. Pinto-Sanchez MI, et al. Nutrition assessment and management in celiac disease. Gastroenterology 2024;167(1):116-31.

Timea Claudia Ghitea | Biomedical science | Women Researcher Award

Published on by Mechanics Awards

Assist. Prof. Dr. Timea Claudia Ghitea | Biomedical science | Women Researcher Award

DOCTOR, UNIVERSITY OF ORADEA, Romania

Timea Claudia Ghitea is a highly experienced professional with a rich background in pharmacy, clinical nutrition, and biomedical sciences. Currently serving as a university assistant at the Faculty of Medicine and Pharmacy in Oradea and a clinical nutritionist at Echo Laboratories, she has developed a strong career spanning over two decades. Ghitea holds a doctorate in biomedical sciences and is committed to advancing research in nutrition, dietetics, and clinical pharmacy. In addition to her academic and clinical work, she actively participates in professional organizations, contributing to the scientific community. As a mentor and project manager, Ghitea has helped guide students and professionals in the medical field. Her multilingual skills (English, French, German, and Spanish) support her international collaborations. A mother of two, she balances her career and personal life while pursuing excellence in her field.

Profile

Education

Timea Claudia Ghitea’s educational journey is marked by a strong commitment to excellence and continuous development. She earned a doctorate in biomedical sciences with a specialization in clinical and sports nutrition in 2020. In 2022, she completed her specialization in nutrition and dietetics at the Faculty of Medicine and Pharmacy in Oradea. She has completed several postgraduate studies in clinical pharmacy and nutrition, such as the Nutrition and Dietetics post-university studies in Timisoara in 2017. Ghitea also holds a Master’s degree in Cell Biology (2006) and a Pharmacy degree from the Faculty of Medicine and Pharmacy, Oradea, in 2006. She has further advanced her education by gaining a solid background in biology and chemistry, earning a degree from the Faculty of Sciences in 2002. Ghitea also completed the Pharmacy Assistant Specialty at Vasile Voiculescu Post-High School in 1999. Her broad academic foundation has shaped her as a leading expert in her fields.

Experience 

Timea Claudia Ghitea has an extensive professional background spanning over 20 years in the pharmacy and clinical nutrition sectors. She has been a University Assistant at the Faculty of Medicine and Pharmacy in Oradea since 2017, where she specializes in nutrition and dietetics. Ghitea also holds the position of Clinical Nutritionist at Echo Laboratories since 2017, focusing on clinical and sports nutrition. Previously, she served as the Pharmacist Director of the Serbian Pharmacy from 2012 to 2017 and MIG3 Pharmacy from 2011 to 2012. Her career began as an Assistant Pharmacist at Delia Pharmacy in 1999, and she later progressed to work at Fontana Pharmacy from 2006 to 2011. Ghitea has also served in leadership roles within the College of Pharmacists Bihor, including as President of the Discipline Committee. Her versatile career demonstrates expertise in both academic and clinical settings, contributing significantly to healthcare.

Research Focus 

Timea Claudia Ghitea’s research interests lie primarily in clinical nutrition, sports nutrition, and biomedical sciences. Her work focuses on how nutrition can affect clinical outcomes, including the management of chronic diseases such as diabetes and osteoporosis. Ghitea’s research also addresses the long-term impacts of long COVID, particularly in relation to cardiomyopathies and mental health disorders. She investigates the interdisciplinary approach to solving complex medical issues through nutritional interventions, collaborating with international colleagues. As part of her expertise in clinical pharmacy, she also explores the relationship between pharmaceutical treatments and their impacts on nutritional status. Additionally, Ghitea has contributed to several research projects related to cardiotoxicity in breast cancer treatment and the impact of vaccination adherence in postpartum mothers. Her academic work aims to bridge the gap between clinical practice and research, focusing on improving patient care through evidence-based nutritional strategies.

Publications

  • The Influence of Osteoporosis and Diabetes on Dental Implant Stability: A Pilot Study 🦷💉
  • Vaccine Adherence: From Vaccine Hesitancy to Actual Vaccination and Reasons for Refusal of Childhood Vaccines in a Group of Postpartum Mothers 💉👩‍👧‍👦
  • Cardiotoxicity in Breast Cancer: Impact of Clinical Classifications and Treatment on Heart Health 💔🎗️
  • Long-term Impacts of Long COVID: Increased Incidence of Cardiomyopathies, Joint Diseases, and Psychoanxiety Disorders 🦠💔
  • Gender-Specific Impacts of the COVID-19 Pandemic on Orthopedic and Traumatology Care: An Analysis of Hospital Admissions and Length of Stay 🏥⚕️

Michael Honaker | Healthcare | Best Researcher Award

Published on by Mechanics Awards

Dr. Michael Honaker | Healthcare | Best Researcher Award

Associate Professor at , East Carolina University, Brody School of Medicine, United States

Dr. Michael Honaker is an Associate Professor of Surgery at East Carolina University’s Brody School of Medicine. Specializing in colorectal surgery, Dr. Michael Honaker serves as Co-Director of Colorectal Surgery at ECU Health and oversees multiple clinical committees. With extensive experience in both academic and clinical roles, Dr. Michael Honaker is dedicated to advancing colorectal cancer care through innovative techniques and improving patient outcomes. A recipient of numerous accolades for excellence in surgery and research, Dr. Michael Honaker is also committed to mentoring medical students and residents. Dr. Michael Honaker actively participates in national surgical societies, contributing to significant clinical research and educational efforts.

Publication Profile

orcid

Education  🎓

Dr. Michael Honaker completed a Bachelor of Science in Biology, magna cum laude, at West Virginia University, followed by a Doctor of Medicine from the West Virginia University School of Medicine, graduating in the top quartile of their class. 🏥 Post-medical education,  Dr. Michael Honaker completed a General Surgery residency at Carolinas Medical Center and subsequently a Fellowship in Colorectal Surgery at William Beaumont Hospital. Dr. Michael Honaker further refined their surgical skills and academic focus during residency and fellowship training, excelling in colorectal surgery.

Experience  💼 

Dr. Michael Honaker has held various academic appointments, currently serving as an Associate Professor of Surgery at ECU’s Brody School of Medicine.
🚑 Previous roles include Assistant Professor of Surgery at Mercer University School of Medicine and Clinical Associate Professor at ECU, where they have also coordinated surgical clerkships for medical students. Clinically,  Dr. Michael Honaker has served at ECU Health as Co-Director of Colorectal Surgery, and prior positions include leadership roles at Navicent Health in Georgia.

Awards & Honors 🏅 

Dr. Michael Honaker has received multiple awards for clinical excellence, including 2nd Place in Best Poster at the William Davidson Medical Education Week in 2016 and an Honorable Mention at Minimally Invasive Week in 2017. Their research on rectal cancer earned them recognition at the Graduate Medical Education Research Week, 2023, for Best Poster. Notably,  Dr. Michael Honaker was elected to the Diseases of the Colon and Rectum Reviewer’s Guild Editorial Board and featured in Digestive Disease Week’s Top Abstracts.

Research Focus 🔬  

Dr. Michael Honaker’s research is centered on colorectal cancer, including clinical trials like JANUS, exploring innovative approaches to improve chemotherapy outcomes.
🚑 Key research areas include improving access to cancer care for rural patients, addressing transportation barriers, and enhancing organ preservation in elderly patients with rectal cancer. Their work also involves developing validated measures for patient risk in cancer care and contributing to precision medicine solutions, funded by Lilly USA.

Publication  Top Notes

  1. Perianal Alveolar Rhabdomyosarcoma – A Rare Case
    Clinical Case Reports, September 2024
    DOI: 10.1002/ccr3.9437
    Contributors: Anas Taha, Amjad Maeky, Larissa Wentzler, Stephanie Taha‐Mehlitz, Robert Rosenberg, Michael D. Honaker.
  2. Postoperative BMI Predictive Model in Bariatric Surgery
    Surgery for Obesity and Related Diseases, July 2024
    DOI: 10.1016/j.soard.2024.06.012
    Contributors: Vincent Ochs, Anja Tobler, Julia Wolleb, Florentin Bieder, Baraa Saad, Bassey Enodien, Laura E. Fischer, Michael D. Honaker, Susanne Drews, Ilan Rosenblum, et al.
  3. Colorectal Cancer Screening and Mortality Disparities
    Journal of Surgical Research, June 2024
    DOI: 10.1016/j.jss.2024.03.040
    Contributors: Michael D. Honaker, Ashley E. Burch, Jan H. Wong, Warqaa M. Akram, William D. Irish.
  4. Virtual Reality in Abdominal Surgery – A Scoping Review
    International Journal of Medical Robotics and Computer Assisted Surgery, February 2024
    DOI: 10.1002/rcs.2623
    Contributors: Vincent Ochs, Baraa Saad, Stephanie Taha‐Mehlitz, Sebastian Staubli, Katerina Neumann, Laura Fischer, Michael D. Honaker, et al.
  5. Rectal Cancer Presentation During COVID-19
    PLOS ONE, September 2023
    DOI: 10.1371/journal.pone.0291447
    Contributors: Tia S. Sutton, Marianna De Camargo Cancela, Scarlett Hao, Mizuki Suzuki, Aimei Chua, Anna Lisa Ciarrocca, Michael D. Honaker.
  6. Rural–Urban Disparities in Colon Cancer Care
    Annals of Surgical Oncology, June 2023
    DOI: 10.1245/s10434-023-13381-y
    Contributors: Michael D. Honaker, William Irish, Alexander A. Parikh, Rebecca A. Snyder.
  7. Emergency Surgery for Diverticulitis – Age and Procedure Outcomes
    Journal of the American Medical Directors Association, April 2022
    DOI: 10.1016/j.jamda.2022.02.001
    Contributors: Seth Quinn, Warqaa Akram, Scarlett Hao, Michael D. Honaker.

Conclusion:

Overall, the candidate presents a well-rounded and distinguished profile, excelling in clinical practice, research, and education. Their leadership in colorectal surgery, research on cancer care, and numerous accolades position them as a highly qualified contender for the Best Researcher Award. With continued growth in securing high-impact grants and international collaborations, their contributions to medical research could expand even further, making them an exemplary researcher and clinician.

Zhiwei Xiong | New Drug Formulations and Technologies | Best Researcher Award

Published on by Mechanics Awards

Dr. Zhiwei Xiong | New Drug Formulations and Technologies | Best Researcher Award 

 Assistant Researcher at  China pharmaceutical university  china

Dr. Xiong Zhiwei is a postdoctoral researcher at China Pharmaceutical University, specializing in innovative pharmaceutical formulations and technologies. With a Ph.D. in Traditional Chinese Medicine, he has made significant contributions to multi-component co-delivery systems and microfluidic technology. Dr. Xiong has published over ten academic papers in prestigious journals, including Int J Biol Macromol and Int. J. Pharm. His work has earned him numerous accolades, including the 74th batch of the China Postdoctoral Science Foundation and selection for the Jiangsu Province “Excellence” Postdoctoral Program. He has been granted four patents and has mentored several master’s students, contributing significantly to the field of intelligent pharmaceutical manufacturing.

Publication Profile

orcid

scopus

Education  🎓

Ph.D. in Traditional Chinese Medicine – China Pharmaceutical University (2019-2022) 🎓 M.S. in Pharmaceutical Preparation – Jiangxi University of Traditional Chinese Medicine (2012-2015) 🎓 B.S. in Traditional Chinese Medicine – Jiangxi College of Traditional Chinese Medicine (2008-2012) Dr. Xiong’s academic journey began with a bachelor’s degree in Traditional Chinese Medicine, which laid the foundation for his expertise in pharmaceutical preparations. He further honed his skills during his master’s and doctoral studies, focusing on novel drug delivery systems. His education has shaped his research into innovative drug technologies and intelligent pharmaceutical manufacturing.

Experience 👨‍🔬

Postdoctoral Researcher – China Pharmaceutical University (Dec 2022 – Present 📚 Full-time Faculty – Jiangxi Science & Technology Normal University (Aug 2015 – Jun 2019)
Dr. Xiong’s professional experience is marked by his current postdoctoral work at China Pharmaceutical University, where he focuses on advanced pharmaceutical technologies such as microfluidic systems and machine vision for intelligent drug manufacturing. Before that, he spent four years as a full-time faculty member at Jiangxi Science & Technology Normal University, where he nurtured future talent in pharmaceutical sciences.

Awards and Honors 🏆 

🏆 Jiangsu Province “Excellence” Postdoctoral Program (2023) 🏅 74th Batch of China Postdoctoral Science Foundation🎖 Awards for Excellence in Scholarship and Research Presentations Dr. Xiong’s exceptional work has earned him several prestigious awards, including the Jiangsu Province “Excellence” Postdoctoral Program recognition in 2023. His contributions to pharmaceutical research have been consistently acknowledged through scholarships and awards for outstanding research presentations, demonstrating his commitment to scientific excellence.

Research Focus  🔬

New Drug Formulations 💊 Multi-component Co-delivery Systems 🌐 Microfluidic Technology 🤖 Machine Vision Online Control for Intelligent Manufacturing
Dr. Xiong’s research revolves around cutting-edge pharmaceutical technologies, focusing on multi-component co-delivery systems and microfluidic technology. His work integrates machine vision for intelligent drug manufacturing, aiming to revolutionize drug delivery and production efficiency. He has led several research projects funded by national and regional grants, contributing to the advancement of intelligent pharmaceutical systems. 

Publication:

1. “Astragalus polysaccharides alleviate type 1 diabetes via modulating gut microbiota in mice” (2023) – 15 citations
2. “Structural elucidation of a novel polysaccharide from Ophiopogonis Radix and its self-assembly mechanism in aqueous solution” (2023) – 18 citations
3. “A review on the applications of Traditional Chinese medicine polysaccharides in drug delivery systems” (2022) – 16 citations (open access)
4. “A new direct compression mechanism of structural transition in Poria cocos extract composite particles” (2022) – 3 citations
5. “Key technologies in dosage form design of Chinese medicinal liquid preparations” (2022) – 1 citation (in Chinese)
6. “Dynamic two-dimensional characterization technique and influencing factors analysis of the hygroscopicity of Chinese medicine extracts” (2022) – 3 citations (in Chinese)
7. “Study on anti-hygroscopic technology based on correlations between particle spatial properties and hygroscopicity of Chinese medicinal extracts” (2021) – (in Chinese)

Conclusion:

In conclusion, Dr. Xiong Zhiwei’s pioneering work in drug delivery systems and pharmaceutical manufacturing technologies makes him a highly deserving nominee for the Best Researcher Award. His combination of academic excellence, patent contributions, and mentorship showcases his dedication to innovation and scientific advancement in the field of pharmaceuticals. Expanding international collaborations and practical applications could be key to further amplifying his already impressive impact.